Clinical Trials on Monoamine Oxidase Inhibitor Activity in United States

Total 1 results

  • Origin Biosciences
    Completed
    Phase 1 Single Dose Study of ALXN1101 in Healthy Volunteers
    Molybdenum Cofactor Deficiency (MoCD) | Rare Autosomal Recessive Disorder | Deficiency of Activity of Molybdenum-dependent Enzymes (Sulfite Oxidase [SOX], Xanthine Dehydrogenase, and Aldehyde Oxidase)
    United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe